Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
D000328:Adult; D000368:Aged; D002220:Carbamazepine / Q000097:blood; D004558:Electric Stimulation; D004576:Electromyography; D004827:Epilepsy / Q000188:drug therapy*; D005013:Ethosuximide / Q000097:blood; D005071:Evoked Potentials; D005260:Female; D005492:Folic Acid / Q000097:blood; D006801:Humans; D008297:Male; D008475:Median Nerve / Q000503:physiopathology; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects; D010525:Peripheral Nerves / Q000187:drug effects* / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000503:physiopathology; D010543:Peroneal Nerve / Q000503:physiopathology; D010634:Phenobarbital / Q000097:blood; D010672:Phenytoin / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D011324:Primidone / Q000097:blood; D011930:Reaction Time; D012023:Reflex, Monosynaptic; D013497:Sural Nerve / Q000503:physiopathology; D013997:Time Factors; D014805:Vitamin B 12 / Q000097:blood
D011324:Primidone; D002220:Carbamazepine; D005013:Ethosuximide; D010672:Phenytoin; D005492:Folic Acid; D014805:Vitamin B 12; D010634:Phenobarbital